Aim: To analyze the bibliometric characteristics, impact, and visibility of scientific publications on artificial intelligence (AI) in dentistry in Scopus.
Materials And Methods: Descriptive and cross-sectional bibliometric study, based on the systematic search of information in Scopus between 2017 and July 10, 2022. The search strategy was elaborated with Medical Subject Headings (MeSH) and Boolean operators. The analysis of bibliometric indicators was performed with Elsevier's SciVal program.
Results: From 2017 to 2022, the number of publications in indexed scientific journals increased, especially in the Q1 (56.1%) and Q2 (30.6%) quartile. Among the journals with the highest production, the majority was from the United States and the United Kingdom, and the Journal of Dental Research has the highest impact (14.9 citations per publication) and the most publications (31). In addition, the Charité - Universitätsmedizin Berlin (FWCI: 8.24) and Krois Joachim (FWCI: 10.09) from Germany were the institution and author with the highest expected performance relative to the world average, respectively. The United States is the country with the highest number of published papers.
Clinical Significance: There is an increasing tendency to increase the scientific production on artificial intelligence in the field of dentistry, with a preference for publication in prestigious scientific journals of high impact. Most of the productive authors and institutions were from Japan. There is a need to promote and consolidate strategies to develop collaborative research both nationally and internationally.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5005/jp-journals-10024-3386 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
EEG-derived brainwave patterns for depression diagnosis via hybrid machine learning and deep learning frameworks.
Appl Neuropsychol Adult
January 2025
Faculty Xavier Institute of Engineering, Mahim, India.
In the fields of engineering, science, technology, and medicine, artificial intelligence (AI) has made significant advancements. In particular, the application of AI techniques in medicine, such as machine learning (ML) and deep learning (DL), is rapidly growing and offers great potential for aiding physicians in the early diagnosis of illnesses. Depression, one of the most prevalent and debilitating mental illnesses, is projected to become the leading cause of disability worldwide by 2040.
View Article and Find Full Text PDFTransformers for Neuroimage Segmentation: Scoping Review.
J Med Internet Res
January 2025
Department of Computer Science and Software Engineering, United Arab Emirates University, Al Ain, United Arab Emirates.
Background: Neuroimaging segmentation is increasingly important for diagnosing and planning treatments for neurological diseases. Manual segmentation is time-consuming, apart from being prone to human error and variability. Transformers are a promising deep learning approach for automated medical image segmentation.
View Article and Find Full Text PDFExploring the Credibility of Large Language Models for Mental Health Support: Protocol for a Scoping Review.
JMIR Res Protoc
January 2025
Data and Web Science Group, School of Business Informatics and Mathematics, University of Manneim, Mannheim, Germany.
Background: The rapid evolution of large language models (LLMs), such as Bidirectional Encoder Representations from Transformers (BERT; Google) and GPT (OpenAI), has introduced significant advancements in natural language processing. These models are increasingly integrated into various applications, including mental health support. However, the credibility of LLMs in providing reliable and explainable mental health information and support remains underexplored.
View Article and Find Full Text PDFEstimating the Prevalence of Schizophrenia in the General Population of Japan Using an Artificial Neural Network-Based Schizophrenia Classifier: Web-Based Cross-Sectional Survey.
JMIR Form Res
January 2025
Department of Public Health, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, 470-1192, Japan, 81 562-93-2476, 81 562-93-3079.
Background: Estimating the prevalence of schizophrenia in the general population remains a challenge worldwide, as well as in Japan. Few studies have estimated schizophrenia prevalence in the Japanese population and have often relied on reports from hospitals and self-reported physician diagnoses or typical schizophrenia symptoms. These approaches are likely to underestimate the true prevalence owing to stigma, poor insight, or lack of access to health care among respondents.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!